Wells Fargo Initiates Coverage on Design Therapeutics with $26 Price Target
Wells Fargo has initiated coverage on Design Therapeutics (DSGN) with a price target of $26.00 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.